BioNexus Gene Lab Corp (NASDAQ: BGLC)
$0.2310
-0.0315 ( +6.45% ) 4.0M
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
Market Data
Open
$0.2310
Previous close
$0.2625
Volume
4.0M
Market cap
$3.83M
Day range
$0.2020 - $0.4070
52 week range
$0.2020 - $3.3900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Sep 05, 2024 |
8-k | 8K-related | 16 | Aug 28, 2024 |
8-k | 8K-related | 20 | Aug 26, 2024 |
10-q | Quarterly Reports | 68 | Aug 14, 2024 |
8-k/a | 8K-related | 20 | Jul 05, 2024 |
10-k/a | Quarterly Reports | 16 | May 31, 2024 |
10-k/a | Quarterly Reports | 16 | May 31, 2024 |
10-q/a | Quarterly Reports | 16 | May 31, 2024 |
10-q/a | Quarterly Reports | 16 | May 31, 2024 |
10-q/a | Quarterly Reports | 16 | May 31, 2024 |